circle animation
circle animation
circle animation
circle animation

Traumatic Brain Injury (TBI)

TBI initiates a cascade of biological responses that extend beyond the initial injury, including neuroinflammation, neuroaxonal damage, and neurodegenerative processes that can persist long after the acute event. As blood-based biomarkers emerge in TBI research, investigators are using complementary biomarker strategies to assess injury severity, monitor recovery, and better understand factors that influence long-term outcomes.

Multiple Sclerosis (5)

Simoa Applications for TBI Research

  • Assess acute brain injury and tissue damage
  • Evaluate neuroinflammatory responses following injury
  • Quantify neuroaxonal injury and degeneration
  • Monitor recovery and longitudinal changes over time
  • Investigate long-term neurological consequences of injury
  • Support patient stratification in translational and clinical research

A Connected Biomarker Portfolio for TBI Research

TBI involves a sequence of biological events that extend beyond the initial injury. Combining biomarkers associated with acute tissue damage, neuroinflammation, neuroaxonal injury, and long-term neurological outcomes can provide a more complete understanding of injury severity, recovery, and biological responses over time. The Simoa portfolio provides biomarker solutions to investigate the evolution of TBI within a single research workflow.

9

Acute Injury

GFAP and UCH-L1 are among the most widely studied biomarkers of acute brain injury. 

GFAP Advantage PLUS

Reflects astrocytic injury and has demonstrated strong diagnostic accuracy for mild TBI

UCH-L1 Advantage PLUS

Associated with neuronal cell body injury

Neurology 4-Plex D (BD-Tau Nf-L, GFAP, UCH-L1) Advantage PLUS

Assessment of neuronal damage from the acute phase through long-term recovery
11

Neuroinflammatory Response

Following impact, neuroinflammatory responses contribute to acute tissue damage and secondary injury following TBI. 

IL-1β Advantage PLUS

Potent pro-inflammatory cytokine that activates the inflammatory response to protect the body against traumatic insults

IL-6 Advantage PLUS

Upregulates in response to tissue damage and stimulates acute immune reactions

 

13

Neuroaxonal Injury

Neuroaxonal injury biomarkers provide insight into neuronal damage following TBI.

BD-Tau Advantage PLUS

Provides brain-specific information related to neuronal injury and has been associated with clinical outcomes following severe TBI

NF-Light Advantange PLUS

Reflects neuroaxonal injury and may remain elevated from the acute phase through long-term recovery

Neurology 4-Plex D (BD-Tau Nf-L, GFAP, UCH-L1) Advantage PLUS

Simultaneous assessment of neuronal injury and glial responses
Neurology (1)

Long-term Neurodegeneration

Neurobiological consequences of TBI may extend years beyond the initial injury. Growing evidence suggests that TBI may initiate biological processes associated with ongoing neurodegeneration.

p-Tau 181 Advantage PLUS

Reflects tau-related pathology

Neurology 2-Plex B (Nf-L + GFAP) Advantage PLUS 

Neuroaxonal damage and astrogliosis

Resources for TBI Research

circle animation
circle animation
circle animation
circle animation

Accelerate Your Traumatic Brain Injury Research

Connect with a Quanterix expert to identify the biomarkers, assays, and research strategies best suited for your neurological disease area and study objectives.

circle animation
circle animation
circle animation
circle animation
Stay Ahead of Biomarker Science

Subscribe to our monthly newsletter for emerging biomarker trends, noteworthy publications, expert perspectives, upcoming events, and practical resources from the Simoa community.